{
    "1703702911023194426": {
        "attachments": {
            "media_keys": [
                "3_1703702906837364736"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-09-18T09:30:01.000Z",
        "edit_history_tweet_ids": [
            "1703702911023194426"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 41,
                    "normalized_text": "transthyretin amyloidosis",
                    "probability": 0.7258,
                    "start": 17,
                    "type": "Other"
                },
                {
                    "end": 141,
                    "normalized_text": "CVRM",
                    "probability": 0.7679,
                    "start": 138,
                    "type": "Other"
                }
            ],
            "urls": [
                {
                    "display_url": "learn.az/6018Po8Ds",
                    "end": 277,
                    "expanded_url": "https://learn.az/6018Po8Ds",
                    "start": 254,
                    "status": 200,
                    "unwound_url": "https://www.astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism/heart-failure.html?utm_source=twitter&utm_medium=cvrm+narrative+roll+out+2023&utm_term=12004&utm_content=cvrm",
                    "url": "https://t.co/vZgpBDuDew"
                },
                {
                    "display_url": "pic.twitter.com/MDHmamWPLT",
                    "end": 301,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1703702911023194426/photo/1",
                    "media_key": "3_1703702906837364736",
                    "start": 278,
                    "url": "https://t.co/MDHmamWPLT"
                }
            ]
        },
        "id": "1703702911023194426",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 4396,
            "like_count": 17,
            "quote_count": 0,
            "reply_count": 0,
            "retweet_count": 5
        },
        "text": "The link between transthyretin amyloidosis and heart failure highlights intricate connections within cardiovascular, renal and metabolic (CVRM) diseases. Learn how understanding this link is crucial for early detection, management and improved outcomes: https://t.co/vZgpBDuDew https://t.co/MDHmamWPLT"
    }
}